Single-Incision Hernia Repair Devices Market: Reducing Scarring and Pain By 2023 to 2033

BySanket Badgujar
Market Research

Hernias can be treated surgically or with careful observation and waiting. The two types of surgical procedures are open tension-free repair surgery and laparoscopic hernia repair. It is predicted that the global Hernia Repair Devices Market will expand over the course of the anticipated period due to the rising prevalence of hernias.

Because of causes like the ageing population, the obesity pandemic, and rapidly shifting lifestyle preferences, hernia prevalence is increasing. Along with the increased inclination for less invasive hernia repair treatments, tension-free hernia repair procedures have become more popular than traditional incisional repair techniques. Because they allow for a quicker recovery with less post-operative discomfort than conventional treatments, tension-free hernia repair procedures are growing in popularity.

Request a sample to obtain authentic analysis and comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14389

The market for hernia repair devices is anticipated to reach US$ 5.0 billion in 2023 and US$ 12.3 billion by 2033, respectively. During the projected period, it is expected that sales of hernia repair equipment will grow significantly (CAGR: 9.4%). The market for hernia repair devices is anticipated to expand through 2032 at an average CAGR of 6.5%, according to a new FMI report.

Key Takeaways:

  • Over the projected period, rising awareness regarding hernias is expected to propel the sales of hernia repair devices. For example, in April 2019, SSM Health Cardinal Glennon Children’s Hospital encouraged awareness among pregnant women by organizing a ‘CDH Care’ Program, which provided information on congenital diaphragmatic hernia (CDH) that would aid them during prenatal diagnosis. April is congenital diaphragmatic hernia (CDH) awareness month at SSM Health Cardinal Glennon Children’s Hospital.
  • Increasing demand for the hernia repair devices market is predicted to profit market players from a focus on regions where composite mesh use is increasing.
  • The key players in the hernia repair devices market are focusing on releasing new items to diversify their product range. For example, ACell, Inc. and Southmedic announced the Gentrix Surgical Matrix series of devices in September 2019, which contains ACell’s MatriStem UBM (Urinary Bladder Matrix) technology. Hernia and abdominal wall repair are treated with the Gentrix Surgical Matrix range of devices.
  • The substantial demand for and acceptance of hernia repair in the United States accounts for North America’s large share of this market. In the United States, the adoption of the hernia repair devices market, particularly biologic mesh devices, is the highest.
  • Hernia repair mesh systems manufacturers will profit from the introduction of innovative and technologically sophisticated hernia repair devices.
  • The market for hernia repair devices is growing as composite mesh methods, which are more expensive, become more popular. The United States, Canada, Germany, France, and other major countries are seeing greater usage of composite meshes.

Competitive Landscape:

In this report, the major players in the hernia repair devices market are Covidien Plc (Medtronic Plc) (Ireland), Ethicon (Johnson & Johnson Services, Inc.) (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard (Becton, Dickinson and Company) (U.S.), W. L. Gore & Associates (U.S.), LifeCell Corporation (Allergan) (Ireland), Maque (U.S.). DIPROMED (Italy), FEG Textiltechnik mbH (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical are some of the other companies in the market (Israel).

Continuous product revisions, followed by technology breakthroughs, and rising demand for less invasive methods, are factors that contribute to the expansion of total hernia repair operations.

However, the high cost of goods and procedures, as well as the uncertainty surrounding reimbursement rules, may restrict the market’s growth prospects.

  • GORE® SYNECOR Intraperitoneal Biomaterial was released in February 2021 by W. L. Gore & Associates in Europe, the Middle East, and South Africa to fulfil unmet requirements in difficult hernia repair.
  • Surgical Innovation Associates’ flagship absorbable mesh, DuraSorb®, gained CE Mark in September 2020 for reconstructive and cosmetic applications, including abdominal hernia prevention, breast tissue support, and prosthetic breast support.
  • W. L. Gore & Associates’ GORE® SYNECOR, a tri-layer hybrid material developed for ease of use during laparoscopic repair devices, robotic, and open surgical operations, obtained a C.E. mark in June 2020.

Key Segments

By Product:

  • Hernia Mesh
    • Biologic
    • Synthetic
  • Fixation Devices
    • Tack
    • Sutures
    • Glue Applicators

By Procedure:

  • Open Surgery
  • Laparoscopic Surgery
  • Robotic Surgery

By Hernia Type:

  • Inguinal Hernia
  • Ventral Hernia
    • Umbilical Hernia
    • Incisional Hernia
    • Epigastric Hernia
  • Femoral Hernia

By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics